Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review

Author(s): Bashir A. Yousef, Hozeifa M. Hassan, Lu-Yong Zhang, Zhen-Zhou Jiang

Journal Name: Current Cancer Drug Targets

Volume 17 , Issue 2 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Graphical Abstract:


Pristimerin, a natural triterpenoid isolated form Celastrus and Maytenus spp, has been shown to possess a variety of biological and pharmacological effects. Recently, pristimerin has attracted more attention, especially for its potential anticancer activities. The anticancer activities of pristimerin have been illustrated in various cancer cell lines and animal models. It has been found to inhibit in vitro and in vivo proliferation, survival, angiogenesis and metastasis of tumor cells. These activities have been attributed to its modulation of various molecular targets such as cyclins, apoptosis- related proteins, proteasome activity, reactive oxygen species, as well as NF-κB, AKT/mTOR and MAPK/ERK pathways. This mini-review discussed the cellular impact and animal studies of pristimerin treatment, with more attention on the various molecular targets of pristimerin.

Keywords: Antitumor agents, natural compounds, NF-κB, pharmacological effects, pristimerin.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [100 - 108]
Pages: 9
DOI: 10.2174/1568009616666160112105824
Price: $65

Article Metrics

PDF: 58